← Back to Search

Pancreatic for Lung Cancer

N/A
Waitlist Available
Research Sponsored by Exact Sciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up point in time (one day) blood collection at enrollment
Awards & highlights

Summary

The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development.

Eligible Conditions
  • Lung Cancer
  • Colorectal Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Bladder Cancer
  • Uterine Cancer
  • Pancreatic Cancer
  • Liver Cancer
  • Stomach Cancer
  • Esophageal Cancer
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~point in time (one day) blood collection at enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and point in time (one day) blood collection at enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biomarker Evaluation

Trial Design

12Treatment groups
Experimental Treatment
Group I: UterineExperimental Treatment1 Intervention
Subjects with clinically confirmed uterine cancer and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.
Group II: StomachExperimental Treatment1 Intervention
Subjects with clinically confirmed stomach cancer and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.
Group III: ProstateExperimental Treatment1 Intervention
Subjects with clinically confirmed prostate cancer and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.
Group IV: PancreaticExperimental Treatment1 Intervention
Subjects with clinically confirmed or suspicion of pancreatic cancer and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.
Group V: OvarianExperimental Treatment1 Intervention
Subjects with clinically confirmed or suspicion of ovarian cancer and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.
Group VI: LungExperimental Treatment1 Intervention
Subjects with clinically confirmed lung cancer and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.
Group VII: LiverExperimental Treatment1 Intervention
Subjects with clinically confirmed liver cancer and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.
Group VIII: Kidney & Renal PelvisExperimental Treatment1 Intervention
Subjects with clinically confirmed or suspicion of kidney or renal pelvis cancer and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.
Group IX: EsophagealExperimental Treatment1 Intervention
Subjects with clinically confirmed esophageal cancer and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.
Group X: ColorectalExperimental Treatment1 Intervention
Subjects with clinically confirmed colorectal cancer and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.
Group XI: BreastExperimental Treatment1 Intervention
Subjects with clinically confirmed breast cancer and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.
Group XII: BladderExperimental Treatment1 Intervention
Subjects with clinically confirmed or suspicion of bladder cancer and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.

Find a Location

Who is running the clinical trial?

Exact Sciences CorporationLead Sponsor
33 Previous Clinical Trials
254,407 Total Patients Enrolled
~733 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top